Resources

#53 Drug: Lenvima (Lenvatinib Mesylate)

Top prescriber in each state and DC based on Medicare Part D records.

Home / Data Tools / Part D Prescribers / Top 100 Drug Pages / Lenvima (Lenvatinib Mesylate)

State-Level #1 Prescriber Table

Drug ranking is based on Medicare Part D drug spending in 2024 (Q1-Q4). Prescriber ranking is based on Medicare Part D prescriber data in 2023.

Top-100 rank metric for this drug: $875,815,079.90 total spending in 2024.

State Prescriber NPI Provider Type Total Claims Total Benes Total Costs
AlabamaArnab Basu1669734083Hematology-Oncology8217$1,855,619.04
AlaskaMelissa Hardesty1821092362Gynecological Oncology20$472,421.40
ArizonaArvind Bakhru1477689511Gynecological Oncology34$736,988.43
ArkansasBalagopalan Nair1063494953Hematology-Oncology27$658,528.59
CaliforniaGauri Kelekar1922250323Hematology-Oncology6311$1,537,431.09
ColoradoManojkumar Bupathi1265675433Internal Medicine27$645,712.28
ConnecticutHari Deshpande1447248117Medical Oncology49$1,220,408.00
DelawareJamil Khatri1427008622Hematology-Oncology13$309,353.33
District of ColumbiaNeil Shah1194084053Hematology-Oncology4615$1,054,903.21
FloridaKedar Kirtane1861767014Internal Medicine43$933,998.15
GeorgiaMehmet Bilen1598085193Hematology-Oncology38$923,509.95
HawaiiJared Acoba1508889338Hematology-Oncology16$361,652.64
IdahoJeffrey Allen1104040104Medical Oncology16$386,636.08
IllinoisGustavo Rodriguez1265527956Obstetrics & Gynecology29$689,277.39
IndianaNabil Adra1811285893Internal Medicine29$704,951.77
IowaJulie Torres1518501659Physician Assistant23$509,298.44
KansasRaed Alrajabi1992798839Hematology-Oncology16$381,651.29
KentuckyKenneth Ain1396857173Endocrinology6111$1,279,228.41
LouisianaJasmine Spearman1477215168Nurse Practitioner25$575,497.23
MaineChristian Thomas1487651584Hematology-Oncology13$342,353.83
MarylandPaige Griffith1639636731Nurse Practitioner30$724,664.11
MassachusettsLori Wirth1750344008Medical Oncology2311$569,754.88
MichiganJared Knol1982867891Hematology-Oncology46$884,143.07
MinnesotaBhaskar Kolla1659535615Internal Medicine27$637,391.53
MississippiMisti Hedgepeth1649753039Nurse Practitioner13$315,011.38
MissouriJaswinder Singh1093747677Hematology-Oncology31$834,834.57
MontanaDavid Christianson1770565871Hematology-Oncology28$555,263.11
NebraskaApar Kishor Ganti1124076997Medical Oncology26$387,192.34
NevadaFadi Braiteh1538268438Medical Oncology15$397,210.44
New HampshireZara Alvi1699329367Internal Medicine12$283,753.93
New JerseyRobert Alter1306805460Hematology-Oncology67$1,544,104.72
New MexicoRamadevi Medavarapu1427298520Hematology-Oncology22$583,408.86
New YorkPaola Degregorio1720147085Physician Assistant5813$1,432,631.66
North CarolinaAsim Amin1518965607Medical Oncology8112$1,947,578.84
North DakotaJeffrey Wiisanen1306282025Hematology17$442,210.13
OhioEdmund Folefac1174540538Medical Oncology63$1,280,335.14
OklahomaEric Thomas1881915940Gynecological Oncology23$508,190.70
OregonTodd Clover1164532107Medical Oncology37$819,313.76
PennsylvaniaMarcia Brose1316975451Medical Oncology17321$4,219,112.96
Rhode IslandLaura Holman1790943314Gynecological Oncology23$555,743.08
South CarolinaTheodore Gourdin1427225069Hematology-Oncology44$943,630.87
South DakotaBenjamin Solomon1912107368Hematology-Oncology12$308,070.74
TennesseeBrian Rini1144261231Hematology-Oncology39$975,929.12
TexasJulie Rowe1851512842Hematology-Oncology7914$2,044,010.90
UtahJeff Russell1790928729Medical Oncology14$352,508.05
VermontAllan Eisemann1801993811Medical Oncology13$293,609.25
VirginiaMark Fleming1457383663Hematology-Oncology31$763,930.98
WashingtonScott Tykodi1114002938Medical Oncology20$490,209.38
West VirginiaNadim Bou Zgheib1386836401Gynecological Oncology26$658,728.23
WisconsinHeidi Larder1346695095Nurse Practitioner23$571,991.73
WyomingSameh Abuerreish1447246202Hematology-Oncology12$284,641.86

Method Note

  • Top 100 drugs are ranked by Tot_Spndng from CMS Part D drug spending data. Brand + generic pair is used for ranking and matching.
  • For each state and DC, the #1 prescriber is selected by highest Tot_Drug_Cst for the same brand + generic pair, using the 2023 prescriber file.
  • If a state has no matching record, values are shown as em dash.

Related Pages

Back to Top 100 drug pages